• Agenda
    • Programs
    • Short Courses
    • Breakout Discussions
    • Plenary Keynote Speaker
    • Young Scientist Keynote
    • Speaker Biographies
    • Attendee List
    • 1-on-1 Networking
    • Event Features
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Exhibitor Prospectus
    • Exhibit Services/Schedule
    • Lead Generation Opportunities
    • FAQ
    • Sponsor & Exhibitor Portal
  • Downloads
    • Brochures
    • Virtual Event Benefit Comparison
  • Posters
    • Posters
    • Poster Titles
  • Media
    • Media Sponsors
    • In the News
    • Podcasts and Interviews
    • Press Releases
  • Register
    • Conference Pricing
    • Group Pricing
    • 2020 On-Demand
    • Press Passes

Emerging Indications for Therapeutic Antibodies

Warning! Web API Url is not set.





Outlook YouTube Facebook LinkedIn Twitter
#PEGS21

Register
Conference at a Glance
Speaker Proposals
Register
TheChain

Premier Sponsors

Charles-River

Ablexis Alivamab_stacked

Evitria_ag_companyLogo

Lonza-tagline-stacked
Sartorius_NEW


2021 PROGRAMS

View By:

      Topic      

      Date      
Engineering
  • Display of Biologics
  • Engineering Antibodies
Oncology
  • Antibodies for Cancer Therapy
  • Driving Clinical Success in Antibody-Drug Conjugates
Bispecific Antibodies
  • Advancing Bispecific Antibodies and Combination Therapy to the Clinic
  • Engineering Bispecific Antibodies
Immunotherpary
  • Improving Immunotherapy Efficacy and Safety
  • CAR Ts, TCRs and TILs
Expression
  • Difficult to Express Proteins
  • Optimizing Protein Expression
Analytical
  • Characterization of Novel Biotherapeutics
  • Biophysical Methods
Covid Interventions
  • Immunogenicity Assessment and Management
Covid Interventions
  • Therapeutic Interventions for COVID-19
  • Accelerating Vaccine Development for COVID-19

May 11 – 12

Therapeutic Interventions for COVID-19

Improving Immunotherapy Efficacy and Safety

Characterization for Novel Biotherapeutics

Difficult-to-Express Proteins

Display of Biologics

Antibodies for Cancer Therapy

Advancing Bispecific Antibodies and Combination Therapy to the Clinic

May 12 – 13

Driving Clinical Success in Antibody-Drug Conjugates

Accelerating Vaccine Development for COVID-19

CAR T, TCRs and TILS

Biophysical Methods

Engineering Antibodies

Optimizing Protein Expression

Engineering Bispecific Antibodies

Immunogenicity Assessment and Management


CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Genomics

Healthcare

IT & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy